Therapy News and Research

RSS

Glioblastomas patients with affected stem cell niche experience progression-free survival

Patients with deadly glioblastomas who received high doses of radiation that hit a portion of the brain that harbors neural stem cells had double the progression-free survival time as patients who had lower doses or no radiation targeting the area, a study from the Radiation Oncology Department at UCLA's Jonsson Comprehensive Cancer Center has found.

26 Jul 2010

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing solutions to the life sciences industries, announce today that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic.

26 Jul 2010

Boehringer Ingelheim announces European CHMP Positive Opinion for TWYNSTA

Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.

26 Jul 2010

Cerenis Therapeutics closes first round of series C, raises €40 million

Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.

26 Jul 2010

North Shore-LIJ Health System seeks oropharynx patients for phase I clinical trial

The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with cancer of the oropharynx (back of the mouth) to participate in a Phase I clinical trial.Subjects must be newly diagnosed and not have undergone any previous treatment. Further, their cancer must be unassociated with the human papilloma virus (HPV-negative), or, if it is HPV-positive, they must be current or former pack-a-day smokers for at least 10 years.

26 Jul 2010

Outcomes selected to administer MTM program for employees in the State of Iowa

Outcomes Pharmaceutical Health Care has been selected by the State of Iowa Department of Administrative Services to administer a Medication Therapy Management program for the state employee health plan.

26 Jul 2010

Scientists develop nanoprobe to detect blood vessel growth in tumors

Formation of new blood vessels, also known as angiogenesis, is crucial for sustained tumor growth and cancer metastasis. Recently, clinically available therapies to suppress the growth of these vessels have been available to improve patient survival in some cancer types. Accurate detection and quantification of blood vessel growth using nonsurgical methods would greatly complement current therapies and allow physicians to quickly assess treatment regimens and adjust them as necessary. In the work published in the August issue of Experimental Biology and Medicine, Kessinger and coworkers have incorporated nanotechnology, material science, and the clinical imaging modality MRI, to create a nanosized probe capable of noninvasively visualizing and quantifying the blood vessel growth in tumors in a preclinical model.

26 Jul 2010

Cancer institute offers new tumor monitoring system for radiation therapy patients

A new system that utilizes a precise a GPS-like system to track prostate cancer tumors is now being offered to patients undergoing radiation therapy at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute. The monitoring system, called Calypso, allows radiation beams to more precisely target the cancer as it gives real-time positioning information that allows the radiation beams to focus directly on the cancer.

23 Jul 2010

Prevalence of HD substantially underestimated in the UK

The prevalence of Huntington's disease is substantially underestimated in the UK, with significant implications for those affected, the healthcare system, and research. New estimates of prevalence, and their implications, are discussed in a comment published in an upcoming Lancet, written by Professor Sir Michael Rawlins, who is the Chairman of the UK National Institute for Health and Clinical Excellence, but writes in his capacity as an Honorary Professor of the London School of Hygiene and Tropical Medicine, UK.

23 Jul 2010

ACLU says some nursing homes use 'scare tactics' to keep psychiatric patients

The American Civil Liberties Union says in court papers that some for-profit nursing home operators are using "scare tactics" to persuade psychiatric patients to stay in their facilities. "The action follows a historic court settlement in which Illinois authorities pledged to offer supportive community-based housing and treatment to roughly 4,500 psychiatric patients who now live in two dozen large nursing homes designated as Institutions for Mental Diseases.

23 Jul 2010

Securing universal access to HIV prevention, care, treatment and support

The biennial meeting of the global AIDS community concluded today with clear evidence of tangible progress in HIV research and programme scale up, yet facing an urgent need for increased resources, the protection of human rights, and broader use of scientifically sound prevention strategies. Delegates and organizers depart Vienna - where the conference opened 18 July under the theme of Rights Here, Right Now -- with a renewed commitment to push for securing universal access to HIV prevention, care, treatment and support.

23 Jul 2010

Today's OpEds: Varying points on the nation's doctor shortage, benefits of negative studies, and what about universal health care?

In the long list of problems affecting the American health care system, the shortage of general practitioners and overabundance of specialists is usually ranked near the top. There is truth to this: only 32 percent of physicians practice primary care medicine. As a result, patients have to wait longer to see their doctors and are more likely to be seen by nurse practitioners and physician assistants instead. However, pediatrics has the opposite problem: a growing shortage of pediatric subspecialists (Dennis Rosen, 7/22).

23 Jul 2010

Vienna Declaration signed to support evidence-based drug policy for improving community health

Sandra Roelofs, First Lady of Georgia; George Tsereteli, Georgia's Deputy Chairman of Parliament; and Irakli Giorgobiani, Georgia's Vice Minister of Labour, Health and Social Affairs, today signed the Vienna Declaration, the official declaration of the XVIII International AIDS conference in Vienna, Austria.

23 Jul 2010

NxStage Medical second-quarter net revenue increases 21% to $44.0 million

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the second quarter of 2010 ended June 30, 2010, with total revenue above the top end of its guidance range.

23 Jul 2010

AIDS 2010 calls for extension of human rights protections as central tenet of global response to AIDS

The appalling lack of access to scientifically proven interventions for key populations at risk -- including sex workers, men who have sex with men and people who use drugs - and the lagging scale up of simple and inexpensive treatment regimens to prevent vertical transmission of HIV reflect persistent, underlying human rights violations that threaten future progress on AIDS, according to organizers of the XVIII International AIDS Conference taking place in Vienna this week under the theme of Rights Here, Right Now.

23 Jul 2010

Emotional barriers, structural barriers can prevent PLWHA from seeking care, treatment: Survey

Bristol-Myers Squibb Company today presented results from a national survey which found that emotional barriers, such as stigma, fear, denial and shame, and structural barriers, such as lack of knowledge, transportation, and insurance coverage, can prevent people living with HIV/AIDS from seeking care and treatment.

23 Jul 2010

New biophotonic imaging method monitors transformations of cellular macromolecules during apoptosis in real-time

Apoptosis, programmed cell death, is essential to normal development, healthy immune system function, and cancer prevention. The process dramatically transforms cellular structures but the limitations of conventional microscopy methods have kept much about this structural reorganization a mystery.

23 Jul 2010

Research on new treatments for FXS to be presented at International Fragile X Conference

Accelerated research findings leading to potentially significant new treatments for fragile X syndrome will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25.

23 Jul 2010

New model for scaling up treatment, prevention of HIV amongst IDUs

Against the backdrop of some of the globe's fastest growing HIV epidemics in Eastern Europe and Central Asia, a report launched today at the XVIII International AIDS conference in Vienna makes the case for a new model for scaling up treatment and prevention of HIV amongst Injecting Drug Users.

23 Jul 2010

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Nevada Cancer Institute (NVCI) is launching its Plus One Program, a paid nursing internship initiative to equip nursing graduates with advanced training to give them an edge in today's competitive nursing job market. After completing a paid one-year internship at NVCI, participants will become oncology nurses, a highly sought-after specialty. These specialized jobs have the potential to pay increased wages, provide excellent benefits and support articulated career ladders within the field of oncology.

23 Jul 2010

Therapy News and Research

Glioblastomas patients with affected stem cell niche experience progression-free survival

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

Boehringer Ingelheim announces European CHMP Positive Opinion for TWYNSTA

Cerenis Therapeutics closes first round of series C, raises €40 million

North Shore-LIJ Health System seeks oropharynx patients for phase I clinical trial

Outcomes selected to administer MTM program for employees in the State of Iowa

Scientists develop nanoprobe to detect blood vessel growth in tumors

Cancer institute offers new tumor monitoring system for radiation therapy patients

Prevalence of HD substantially underestimated in the UK

ACLU says some nursing homes use 'scare tactics' to keep psychiatric patients

Securing universal access to HIV prevention, care, treatment and support

Today's OpEds: Varying points on the nation's doctor shortage, benefits of negative studies, and what about universal health care?

Vienna Declaration signed to support evidence-based drug policy for improving community health

NxStage Medical second-quarter net revenue increases 21% to $44.0 million

AIDS 2010 calls for extension of human rights protections as central tenet of global response to AIDS

Emotional barriers, structural barriers can prevent PLWHA from seeking care, treatment: Survey

New biophotonic imaging method monitors transformations of cellular macromolecules during apoptosis in real-time

Research on new treatments for FXS to be presented at International Fragile X Conference

New model for scaling up treatment, prevention of HIV amongst IDUs

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News